Abstract

http://ssrn.com/abstract=1976372
 
 

References (11)



 
 

Citations (1)



 


 



What Do Drug Monopolies Cost Consumers in Developing Countries?


Rebecca Hellerstein


Federal Reserve Bank of New York

December 1, 2011

FRB of New York Staff Report No. 530

Abstract:     
This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Number of Pages in PDF File: 11

Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups

JEL Classification: D4, F13, L1, L65, O34

working papers series





Download This Paper

Date posted: December 24, 2011  

Suggested Citation

Hellerstein, Rebecca, What Do Drug Monopolies Cost Consumers in Developing Countries? (December 1, 2011). FRB of New York Staff Report No. 530. Available at SSRN: http://ssrn.com/abstract=1976372 or http://dx.doi.org/10.2139/ssrn.1976372

Contact Information

Rebecca Hellerstein (Contact Author)
Federal Reserve Bank of New York ( email )
33 Liberty Street
New York, NY 10045
United States
Feedback to SSRN


Paper statistics
Abstract Views: 276
Downloads: 54
Download Rank: 230,282
References:  11
Citations:  1

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.344 seconds